Hynts Tech

What Hynts Tech does

Hynts Tech Corporation is a Japan-based nanotechnology startup, founded in July 2021 as a Waseda University spin-off headquartered in Kitakyushu, Fukuoka. The company develops and manufactures the NanoTube Membrane Stamp (NTs membrane stamp), a proprietary nanostructured thin-film tool featuring controlled-diameter hollow nano-tubes (available in approximately 1.0μm, 800nm/600nm, and 400nm configurations) that physically punctures cell membranes to enable direct delivery of macromolecules such as proteins and extraction of intracellular substances, bypassing the endocytosis-dependent limitations of conventional transfection methods. Its product line includes the consumable NTs membrane stamp (sold in 12-bottle kits), the NTs membrane Stamping System (a microscope-mounted, custom-manufactured device built to customer specifications), a limited-time cell processing evaluation service, and an R&D support service for cell processing applications.

Hynts Tech generates revenue through direct, inquiry-based hardware sales and professional services, with all pricing handled via confidential quotation. Its primary customer segment is regenerative medicine and cell therapy researchers and companies, with secondary segments in life sciences research institutions, pharmaceutical and biotechnology drug discovery teams, and nascent food/environment/bio-manufacturing applications. The company sells through direct consultation supplemented by conference presence at venues such as the Japanese Society for Regenerative Medicine annual meetings and BIO International Convention. As of November 2025, Hynts Tech is seed-stage with 1–10 employees, and is in a major growth phase heading into its fifth anniversary, having secured a partnership with Ebara Corporation in August 2024 to co-develop an automated cell processing device aimed at clinical and commercial-scale regenerative medicine manufacturing.

The go-to-market motion is event-driven and sales-led, anchored by major industry conferences (JSRM annual meetings, BIO International) and direct inquiry channels, supported by a continuous grant and accelerator track record including NEDO, JETRO, METI Go-Tech, Berkeley SkyDeck, and Mitsubishi UFJ Foundation selections. The company's strategic posture is transitioning from a single-product research tool vendor toward an automated instrumentation platform play through the Ebara partnership, targeting the clinical translation bottleneck in regenerative medicine and cell therapy manufacturing.

Name

Hynts Tech

Legal name

Hynts Tech Corporation

Website

https://hyntstech.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Hynts Tech Corporation is a Japan-based nanotechnology startup that manufactures the NanoTube Membrane Stamp (NTs membrane stamp), a proprietary nano-structured tool that punctures cells to deliver macromolecules and extract intracellular substances, serving regenerative medicine researchers, life sciences institutions, and pharmaceutical/biotech companies through direct inquiry-based sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Kitakyushu

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Product Sales - NTs membrane stamp: Sale of the NanoTube Membrane Stamp (NTs membrane stamp), a specialized nanostructured tool for cell manipulation. Sold in kit units of 12 bottles. Order specifications include nanotube diameter preferences.
2. NTs membrane Stamping System: Sale of the microscope-mounted NTs membrane Stamping System, which is custom manufactured based on the customer's microscope model and specifications.
3. Cell Processing Evaluation Service: Limited-time evaluation service for prospective customers to test the extent of substance introduction possible using the NTs membrane stamp. Helps customers evaluate technology adoption before purchasing products.
4. Research and Development Support Services: R&D support services utilizing the NTs membrane Stamping System for customers requiring assistance with cell processing applications.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Hynts Tech Corporation manufactures and sells the NanoTube Membrane Stamp (NTs membrane stamp), a nanostructured thin-film tool with nano-scale hollow tubes that punctures cells directly to enable highly efficient introduction of macromolecules such as proteins and extraction of intracellular substances, with high cell viability and short processing times. The company also sells the NTs membrane Stamping System, a microscope-mounted device custom-manufactured to customer specifications, and offers a limited-time cell processing evaluation service for prospective adopters.

Differentiator

Problem solved

Functional benefit

Products and services

• NTs membrane stamp A membrane with a unique nanostructure featuring nano-scale hollow tubes that enables highly efficient introduction of macromolecules such as proteins into cells and extraction of intracellular substances, with high cell viability and short processing times. Sold in kits of 12 bottles with configurable nanotube diameters.
• NTs membrane Stamping System A microscope-mounted system for puncturing cells with the NTs membrane stamp. Custom manufactured based on the customer's microscope model and size specifications. Automates cell processing and improves efficiency and reproducibility for regenerative medicine and cell therapy applications.
• Cell Processing Evaluation Service Limited-time evaluation service for prospective customers considering adoption of the NTs membrane stamp. Confirms the extent of substance introduction achievable using the product to support customer evaluation prior to purchase.

Quantifiable outcome

• High efficiency introduction of macromolecules in short time with high cell viability

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered flagship, core and minor.

• Japan External Trade Organization (JETRO)flagshipGTM or Marketing Partner · 1 January 2026Selected as exhibitor in the Japan Pavilion at BIO International Convention 2026, one of the world's largest international business partnering events in biotechnology. JETRO organizes the Japan Pavilion, providing a platform for Hynts Tech to showcase technologies to a global audience of over 20,000 industry professionals including pharmaceutical companies, biotech companies, research institutions, and investors.
• Ebara Corporation (荏原製作所)coreStrategic or Co-development Partner · 30 August 2024Joint development project for industrialization of automated cell processing device. Ebara brings its expertise in fluid analysis, control, and automation technologies to complement Hynts Tech's innovative cell processing tool (NTs membrane stamping system). The collaboration aims to develop an easy-to-operate and cost-competitive industrial system for automated cell processing, supporting the clinical application of regenerative medicine and cell therapy.
• Berkeley SkyDeckcoreGTM or Marketing Partner · 1 January 2022Participated in the Berkeley SkyDeck Batch15 Innovation Partner Program through JETRO's Startup City Acceleration Program 2022. The program provided international exposure and networking opportunities with the global startup ecosystem.
• Biotech Partner (unnamed)minorOthersHynts Tech seeks partners for application development in healthcare, environment, and food sectors. Looking for R&D departments, business development divisions of companies handling cells, and universities/research institutions for collaborative application development.
• Strategic Partner (unnamed)minorOthersHynts Tech seeks partners for cell processing device and related tool development, manufacturing strengthening, and market expansion. Looking for CDMO companies for cell manufacturing contracting, equipment developers, material manufacturers, sales partners (distributors, trading companies), cell transport partners, and OEM/joint brand development partners.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Lonza: Global CDMO with large cell and gene therapy manufacturing services. While not a tool vendor, Lonza represents the type of clinical-scale manufacturing customer that Hynts Tech's automated cell processing system (with Ebara) is being designed to supply.
• Bio-Techne: Diversified life science research tools provider with cell biology, gene editing, and protein delivery reagent portfolios. Comparable in serving the same research customers but competes through breadth rather than a focused nano-stamping platform.
• Thermo Fisher Scientific: Global life sciences giant with dominant transfection reagent franchises (Lipofectamine) and cell therapy manufacturing capabilities. Competes with Hynts Tech broadly in the cell manipulation workflow but does not focus on nanotube-based delivery.

Direct peers

• MaxCyte: Developer of flow electroporation technology for cell engineering, with a strong focus on cell therapy and gene editing manufacturing. Comparable to Hynts Tech as both sell cell manipulation platforms targeting regenerative medicine and gene therapy workflows.
• Nepa Gene: Japan-based provider of electroporation and sonoporation instruments for intracellular delivery of nucleic acids and proteins. Closely comparable to Hynts Tech in both technology class (cell permeabilization for macromolecule delivery) and geography.
• Celetrix: Manufacturer of high-voltage electroporation systems optimized for difficult-to-transfect cells including primary and stem cells. Comparable to Hynts Tech in serving researchers needing efficient intracellular delivery into recalcitrant cell types.
• Mirus Bio: Developer of TransIT-branded transfection reagents and electroporation solutions for gene delivery in research and bioprocessing. Comparable to Hynts Tech as a cell engineering tool vendor addressing the same workflow of introducing cargo into cells.
• BEX Co., Ltd. Japanese supplier of electroporation devices and cell transfection tools used in academic and biotech research. Comparable in product category (transfection hardware) and customer base, with a similar domestic-Japan commercial footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/HyntsTech
• LinkedInlinkedin.com/company/hynts-tech-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hynts Tech